GlassScriptPhysician profile
Rashid Khalil
NPI 1003000142
$12,793.31
in general payments reported to CMS, 2019-2025
21 companies · $439 in 2025
The $439 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $251 · 2021: $2,417 · 2022: $3,544 · 2023: $3,069 · 2024: $1,769 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,856 · Travel and Lodging: $822 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,855.95 |
| Travel and Lodging | $821.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $3,251.79 | 2020-2023 | Intracept |
| Boston Scientific Corporation | $2,022.03 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,726.31 | 2021-2024 | Proclaim, Ionicrf |
| Medtronic, INC. | $1,517.23 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $1,057.14 | 2019 | |
| Spr Therapeutics, INC | $1,020.99 | 2023 | Sprint Pns System |
| Vertos Medical, INC. | $998.84 | 2021-2024 | Mild Device Kit |
| Nevro Corp. | $501.90 | 2020-2024 | Senza |
| Stryker Corporation | $284.11 | 2023-2025 | Omnicurve, Spinejack, Augment Injectable |
| Myoscience INC. | $124.99 | 2019 | |
| Allergan, INC. | $71.58 | 2021-2022 | |
| Amgen INC. | $34.23 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $31.92 | 2022 | |
| Abbvie INC. | $28.88 | 2021 | |
| Scilex Pharmaceuticals INC. | $24.13 | 2023 | Ztlido |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.59 | 2022 | |
| Merck Sharp & Dohme LLC | $16.89 | 2021 | |
| Avanos Medical | $16.08 | 2019 | |
| Medline Industries LP | $14.71 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashid Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.